I:

Monique Hinchcliff1, Dinesh Khanna2, Enrico De Lorenzis3

  • 1Department of Internal Medicine, Section of Rheumatology, Allergy, and Immunology, Yale School of Medicine, New Haven, CT, USA.

PubMed
概括

血清干扰素 (IFN) 评分可以识别患有扩散性皮肤全身性硬化症的患者,这些患者的疾病活性较高,预后更差. 这一发现有助于预测这些患者的结果和生存率.